I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 16 studies | 23% ± 6% | |
| naive B cell | 10 studies | 18% ± 3% | |
| adipocyte | 9 studies | 31% ± 9% | |
| natural killer cell | 7 studies | 20% ± 3% | |
| pericyte | 6 studies | 26% ± 5% | |
| epithelial cell | 6 studies | 37% ± 13% | |
| type I pneumocyte | 6 studies | 25% ± 8% | |
| type II pneumocyte | 6 studies | 26% ± 8% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 18% ± 4% | |
| endothelial cell | 5 studies | 24% ± 8% | |
| fibroblast | 5 studies | 21% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 19% ± 3% | |
| cardiac muscle cell | 4 studies | 21% ± 4% | |
| mesothelial cell | 4 studies | 27% ± 5% | |
| GABAergic neuron | 4 studies | 30% ± 10% | |
| club cell | 4 studies | 21% ± 7% | |
| basal cell | 4 studies | 33% ± 17% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 19% ± 4% | |
| ciliated cell | 3 studies | 25% ± 4% | |
| lymphocyte | 3 studies | 24% ± 3% | |
| germinal center B cell | 3 studies | 27% ± 2% | |
| glutamatergic neuron | 3 studies | 44% ± 14% |
